+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07613840

Personalized Blood Clot Prevention After Surgery for Peripheral Artery Disease to Improve Outcomes

Led by Massachusetts General Hospital · Updated on 2026-09-11

484

Participants Needed

2

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a personalized blood clot prevention plan compared to standard treatment in adults with peripheral artery disease PAD who have undergone procedures to restore blood flow to their legs. This study aims to see if the personalized plan reduces blood clots, amputations, repeat procedures, bleeding, and death over one year. The personalized approach uses a blood test to tailor blood clot prevention medications. Participants are randomly assigned to either the personalized TARGET plan or standard treatment. The TARGET plan uses serial Thromboelastography with Platelet Mapping TEG-PM blood tests at 1 week and at 1, 3, 6, 9, and 12 months after the procedure to adjust antiplatelet medications and maintain platelet inhibition within a therapeutic range. The standard treatment group receives usual care with no medication changes based on TEG-PM results. Throughout the study, blood tests are collected regularly to monitor coagulation and platelet function. Researchers measure the incidence of arterial thrombosis in the treated limb and track rates of amputation-free survival, mortality, repeat interventions, and bleeding events up to 12 months after revascularization. Medication adjustments are made in the TARGET group based on test results, and all participants are followed for one year to assess outcomes and safety.

CONDITIONS

Brief Title

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

Research Team

A

Anahita Dua, MBCHB, MBA, MSC

S

Swechha Bhatt, MBBS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here